UK markets closed

Inotiv, Inc. (NOTV)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
26.17+2.17 (+9.04%)
At close: 04:00PM EDT
26.17 0.00 (0.00%)
After hours: 05:40PM EDT

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Aug. 15, 2022.

Sign in to post a message.
  • a
    allen
    is any
  • t
    tokkeloshe
    Investigator bonds with monkeys in lab
    www.youtube.com
  • T
    Theta
    Long and fing strong on this company.
  • r
    richard
    It was a good post. I have followed this company for years. They now have aggressive management, they will be looking for more acquisitions, revenue will continue to grow, earnings will follow, but current emphasis is revenue growth both internal and external. Hedge fund or Mutual fund might be behind the increased volume along with Buy Recommendation from Collier. Hot Sector.
  • o
    oliver
    long
  • D
    Delta
    Buyers 2/2/21 1,567,840 $18,108,552 39.10%
    A large institutional buy, this is significant because of the low issued share count of 11M
  • D
    Delta
    Bioanalytical Sys. initiated with a Buy at Colliers Securities; tgt $17
    2:46 PM ET 12/22/20 |
    . Analyst Kyle Bauser said, "We are initiating coverage of Bioanalytical Systems (dba Inotiv) with a Buy rating and $17 Price Target. BASI is a contract research organization (CRO) that provides nonclinical and analytical contract research services to life science companies. Currently trading at roughly half the peer group average, we believe there is considerable upside to BASI shares, particularly given its premium growth rate. Following channel checks with several biotech companies, we learned that not only does BASI have a full range of service offerings, but the company's customer service and quality make it undoubtedly the best-in-class CRO. Our $17 Price Target assumes a 3.2x EV/sales multiple (peer group average) applied to $69.2M CY21E sales, $26.0M net debt, and 11.6M FD shares."
  • I
    Insideout
    Stock is down over 50% in the past week or so. Anyone have any ideas why?
  • j
    joe
    sold none today looks like we are gonna go parabolic now big move
  • S
    Savannah
    BIOANALYTICAL SYSTEMS INC
    Annual Report From SEC on 10-K
    https://sec.report/Document/0001104659-19-076191/
    Security and Exchange Commission SEC Bioanalytical Systems Inc Form 10-K
    Security and Exchange Commission SEC Bioanalytical Systems Inc Form 10-K
    sec.report
  • j
    joe
    sold the rest today just under 5 great ride
  • D
    Delta
    I am liking my own posts since nobody else is. : )
  • D
    Delta
    Shorts are getting what they deserve here.
  • L
    Long Term
    Another insider buying report after the close today - operations manager acquired shares at $3.45 yesterday.
  • W
    Wade
    One to watch.
  • D
    Delta
    The company will host it's inaugural conference call coinciding with it's next earning report. BASI (soon to be Inotiv) will be a solid long term winner.
  • D
    Delta
    CRO, do your DD. Not many CRO's trading at $9, like 0 besides this one. They all start down here and inevitably go up up up.